M. R. Globa
M. R. Globa has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Leonid Mihailovich Elin
Moscow Regional Scientific Research Clinical Institute M.F. Vladimirsky, Moscow, Russian Federation.
2 shared publications - D. I. Nam
Pirogov Russian National Research Medical University of the Ministry of Health
1 shared publication - Dmitriy Anatolyevich Pyhteev
M.F. Vladimirsky Moscow Regional Research Clinical Institute
1 shared publication Dmitry Anatolievich Pykhteev
1 shared publication- H. A. Sarkisyan
Pirogov Russian National Research Medical University
1 shared publication - I. D. Prokhorov
Pirogov Russian National Research Medical University of the Ministry of Health
1 shared publication
Latest Publications
- Open Access
- 17 January 2025
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 1,p. 154-158
Hereditary type V hyperlipidemia as an etiological factor of severe necrotizing pancreatitis
Acute pancreatitis (AP) remains a relevant issue in pediatric surgery. One of the risk factors for the development of AP is hereditary hypertriglyceridemia, which is often diagnosed only at the time of AP exacerbation. This article presents a clinical case of necrotizing pancreatitis of a 16-year-old girl with hereditary hypertriglyceridemia (type V hyperlipidemia). The management strategy for the child is described, with a comprehensive overview of diagnostic and therapeutic measures taken. Emphasis is placed on the main mechanisms of the inflammatory process’s pathogenesis. The necessity of timely diagnosis of lipid metabolism disorders and identifying factors contributing to AP development is highlighted to prevent potentially life-threatening conditions.
- 17 January 2025
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 1,p. 154-158
Open AccessHereditary type V hyperlipidemia as an etiological factor of severe necrotizing pancreatitis
Acute pancreatitis (AP) remains a relevant issue in pediatric surgery. One of the risk factors for the development of AP is hereditary hypertriglyceridemia, which is often diagnosed only at the time of AP exacerbation. This article presents a clinical case of necrotizing pancreatitis of a 16-year-old girl with hereditary hypertriglyceridemia (type V hyperlipidemia). The management strategy for the child is described, with a comprehensive overview of diagnostic and therapeutic measures taken. Emphasis is placed on the main mechanisms of the inflammatory process’s pathogenesis. The necessity of timely diagnosis of lipid metabolism disorders and identifying factors contributing to AP development is highlighted to prevent potentially life-threatening conditions.
- Open Access
- 23 March 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (1) , 35-43
Non-immune hydrops fetalis: etiology, pathogenesis, features of diagnosis and treatment in the fetus and newborn
Non-immune hydrops fetalis is a polyetiological disease characterized by high perinatal mortality. The development of non-immune fetal hydrops is associated with diseases of the cardiovascular and lymphatic systems, genetic and chromosomal diseases, infectious agents and many other reasons. In this regard, there is no single approach to the treatment of this extremely dangerous pathological condition, which requires the joint work of specialists from different specialties: obstetricians-gynecologists, neonatologists, cardiologists, surgeons, hematologists and geneticists. This article provides a review of current literature data on the etiology, pathogenesis, clinical manifestations, treatment and outcomes of non-immune hydrops fetalis.
- 23 March 2024
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 23 (1) , 35-43
Open AccessNon-immune hydrops fetalis: etiology, pathogenesis, features of diagnosis and treatment in the fetus and newborn
Non-immune hydrops fetalis is a polyetiological disease characterized by high perinatal mortality. The development of non-immune fetal hydrops is associated with diseases of the cardiovascular and lymphatic systems, genetic and chromosomal diseases, infectious agents and many other reasons. In this regard, there is no single approach to the treatment of this extremely dangerous pathological condition, which requires the joint work of specialists from different specialties: obstetricians-gynecologists, neonatologists, cardiologists, surgeons, hematologists and geneticists. This article provides a review of current literature data on the etiology, pathogenesis, clinical manifestations, treatment and outcomes of non-immune hydrops fetalis.